FdaApplication
BLA 761118
Identifiers
- fda_app_no: BLA761118
Properties
| Property | Value |
|---|---|
| applicant_name | Pfizer Inc. |
| application_type | BLA |
| approval_date | 2019-11-15 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABRILADA | ADALIMUMAB-AFZB | 40MG/0.8ML | Injection |
| ABRILADA | ADALIMUMAB-AFZB | 40MG/0.8ML | Injection |
| ABRILADA | ADALIMUMAB-AFZB | 20MG/0.4ML | Injection |
| ABRILADA | — | 40MG/0.8ML | Injection |
| ABRILADA | — | 10MG/0.2ML | Injection |
5 products